M.P.C. Campello, a researcher at the Instituto Superior Técnico, University of Lisbon, Center for Nuclear Sciences and Technologies (C2TN), Radiopharmaceutical Sciences Group since 2000, has focused her research on designing and synthesizing new molecular and nanometric (radio)compounds for diagnostic and therapeutic applications in cancer and nuclear medicine. The multidisciplinary nature of his research has fostered interaction with several national and international scientists from different research groups with experience in chemistry, radiochemistry, radiopharmacy and biochemistry. Her research endeavors encompass diverse domains of chemistry, spanning inorganic and organic chemistry, alongside radiochemistry. Her expertise lies in developing and evaluating new linear and macrocyclic multifunctional ligands suitable for coordinating d- and f- elements, contributing to the design of novel radiopharmaceuticals for nuclear (SPECT/PET) and MRI imaging, as well as cancer therapy. Additionally, she specializes in synthesizing biomolecular peptides and radiolabeling compounds with various metal radionuclides (64Cu, 67Ga, 99mTc, 111In, 153Sm). Notably, her recent research has underscored the potential of specific multifunctional gold nanoparticles as emerging diagnostic and therapeutic platforms. Synthesized using a novel macrocycle developed by M.P.C. Campello, these nanoparticles not only demonstrate high stability but also exhibit a significant capability to form stable (radio)complexes, crucial for applications in MRI (Gd), PET (67Ga) molecular imaging, and radiotherapy (177Lu) or anticancer agents upon radiosensitisation. Moreover, when adorned with biomolecules, they enable targeted recognition of overexpressed membrane receptors in tumor cells, enhancing their potential utility. More recently, she has been involved in the development and evaluation of superparamagnetic iron oxide nanoparticles for use in magnetic hyperthermia and magnetic resonance imaging (MRI). She supervised 3 master's theses, leveraging her experience. Her expertise has played a pivotal role in her involvement as a researcher in 11 competitively funded national and international projects, notably including the ongoing European Commission-funded project - PRISMAP: European medical radionuclide program on the production of high-purity radionuclides by mass separation (Grant agreement ID: 101008571 - 2021-2025). M.P.C. Campello's research contributions comprise the authorship of 63 articles in peer-reviewed journals, with approximately 90% published in Q1 journals, alongside 2 book chapters. Her research has been cited more than 1660 times, reflecting a remarkable impact (H index 23 and i10 index 43, SCOPUS). She has supervised 9 master's dissertations and is currently co-supervising a PhD thesis, demonstrating her commitment to mentoring and academic advancement in her field.